DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
HIV-2 Immature Particle Morphology Provides Insights into Gag Lattice Stability and Virus Maturation
Retrovirus immature particle morphology consists of a membrane enclosed, pleomorphic, spherical and incomplete lattice of Gag hexamers. Previously, we demonstrated that human immunodeficiency virus type 2 (HIV-2) immature particles possess a distinct and extensive Gag lattice morphology. To better understand the nature of the continuously curved hexagonal Gag lattice, we have used the single particle cryo-electron microscopy method to determine the HIV-2 Gag lattice structure for immature virions. The reconstruction map at 5.5 Å resolution revealed a stable, wineglass-shaped Gag hexamer structure with structural features consistent with other lentiviral immature Gag lattice structures. Cryo-electron tomography provided evidence for nearly complete ordered Gag lattice structures in HIV-2 immature particles. We also solved a 1.98 Å resolution crystal structure of the carboxyl-terminal domain (CTD) of the HIV-2 capsid (CA) protein that identified a structured helix 12 supported via an interaction of helix 10 in the absence of the SP1 region of Gag. Residues at the helix 10-12 interface proved critical in maintaining HIV-2 particle release and infectivity. Taken together, our findings provide the first 3D organization of HIV-2 immature Gag lattice and important insights into both HIV Gag lattice stabilization and virus maturation., This work is supported by NIH grant R01 AI177264 (to L.M. and W.Z.). Support is also acknowledged from NIH grants R35 GM118047 (to H.A.) and R21 AI148328 (to W.Z. and L.M.). D.C.D. acknowledges the support of the grant 205321/179041 of the Swiss National Science Foundation (SNF), the grant RGP0017/2020 of the Human Frontiers Science Program (HFSP), and funding from the project PID2021-127309NB-I00 funded by AEI/10.13039/501100011033/ FEDER, UE. This research was, in part, supported by the National Cancer Institute’s National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research under contract HSSN261200800001E. Parts of this work were carried out in the Characterization Facility, University of Minnesota, which receives partial support from the NSF through the MRSEC (Award Number DMR-2011401) and the NNCI (Award Number ECCS-2025124) programs., N.T. was supported by NIH grants T32 DA007097, F32 AI150351, and American Cancer Society Postdoctoral Fellowship PF-21-189-01-MPC. W.G.A. was supported by the Institute for Molecular Virology Training Program (i.e., NIH grant T32 AI83196)., Peer reviewed
Proyecto:
AEI PID2021-127309NB-I00
DOI: http://hdl.handle.net/10261/339138, https://api.elsevier.com/content/abstract/scopus_id/85162759391
HANDLE: http://hdl.handle.net/10261/339138, https://api.elsevier.com/content/abstract/scopus_id/85162759391